UAB Digital Repository of Documents 1 records found  Search took 0.00 seconds. 
1.
8 p, 843.7 KB The impact of onabotulinumtoxinA on severe headache days : PREEMPT 56-week pooled analysis / Matharu, Manjit (Queen Square, London, WC1N3BG UK) ; Halker, Rashmi (East Mayo Blvd, Phoenix, AZ 85054 USA) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; DeGryse, Ronald (Allergan plc, 2525 Dupont Dr, Irvine, CA USA) ; Manack Adams, Aubrey (Allergan plc, 2525 Dupont Dr, Irvine, CA USA) ; Aurora, Sheena K. (Pasteur Dr. Room A301 MC 5325, Stanford, CA USA) ; Universitat Autònoma de Barcelona
OnabotulinumtoxinA has been shown to reduce headache-days among patients with chronic migraine (CM). The objective of this analysis was to determine whether onabotulinumtoxinA has an impact on headache-day severity in patients with CM among those patients who were deemed non-responders based on reduction in the frequency of headache days alone. [...]
2017 - 10.1186/s10194-017-0784-4
Journal of headache and pain, Vol. 18 (august 2017)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.